Cortex Pharmaceuticals is a clinical-stage specialty pharmaceutical company chiefly engaged in the discovery, development and commercialization of positive AMPA-type glutamate receptor modulators. The company has created a class of proprietary pharmaceuticals called AMPAKINE compounds, which act to increase the strength … Continue reading →

Keryx Biopharmaceuticals specializes in acquiring, developing and commercializing medically important pharmaceutical products to treat renal disease. The company is developing Zerenex (ferric citrate), an oral, ferric iron-based compound with the capability of binding to phosphate and forming non-absorbable complexes. Zerenex’s … Continue reading →

DURECT Corporation is a specialty pharmaceutical company focused on developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil. The company’s proprietary oral, transdermal and injectable depot delivery technologies facilitate new indications … Continue reading →

Supernus Pharmaceuticals is a specialty pharmaceutical company engaged in the development and commercialization of products for treating central nervous system (CNS) diseases. The company is in the process of developing several product candidates in neurology and psychiatry to address large … Continue reading →

PC Mall, through its wholly owned subsidiaries, is a leading value-added direct marketer of technology products, services and solutions. The company’s clients include small and medium-sized businesses, mid-market and enterprise customers, government and educational institutions and individual customers. PC Mall’s … Continue reading →

Stevia First is an early-stage agribusiness seeking to establish a vertically integrated stevia enterprise in the United States. Based in the growing region of California’s Central Valley, the company has expertise in stevia seed and tissue propagation, plant breeding and … Continue reading →

Spectral Diagnostics is a Phase III company focused on the development of the first theranostic treatment for patients with septic shock. The company is currently seeking FDA approval for Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. … Continue reading →

Chelsea Therapeutics International is a biopharmaceutical company engaged in acquiring and developing innovative products to treat a variety of human diseases, including disorders of the central nervous system. The company is presently pursuing FDA approval in the United States for … Continue reading →

OncoSec Medical is a biopharmaceutical company engaged in developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies for the treatment of solid tumor cancers and metastatic disease. Addressing an unmet medical need, OMS ElectroOncology therapies represent a potential solution for … Continue reading →

eMagin Corp. is a leading provider of OLED microdisplay technology and personal display systems. The company integrates high-resolution OLED microdisplays with magnifying optics to deliver virtual images in portable, low-power, lightweight personal displays that are comparable to large-screen computer and … Continue reading →